Significance of pretreatment serum hemoglobin and survival in epithelial ovarian cancer.
Tumor anemia is common in patients with malignant tumors and it was repeatedly demonstrated to be associated with impaired prognosis in patients with malignant tumors. We conducted a retrospective analysis based on 553 patients with histologically proven epithelial ovarian cancer. Blood hemoglobin levels were determined before surgery and patients with values <12 g/dl were considered anemic. Data analysis included univariate and multiple Cox models. Tumor anemia was present in 143 (25.9%) patients before surgery. Tumor anemia was present in 143 (25.9%) patients before surgery. In a multivariate Cox model, pretreatment hemoglobin values proved to be an independent prognostic factor for patients with stage I-II epithelial ovarian cancer (n=203), but failed to attain significance in patients with stage III-IV disease (n=350). Tumor anemia defined as pretreatment hemoglobin values <12 g/dl may indicate patients with stage I and II epithelial ovarian cancer, who are at increased risk of relapse.
Obermair
A
A
University Hospital of Vienna, Department of Gynecology and Obstetrics, Waehringer Guertel, Vienna, Austria.
Petru
E
E
Windbichler
G
G
Peters-Engl
C
C
Graf
A H
AH
Stummvoll
W
W
Kaider
A
A
Kurschel
S
S
Kölbl
H
H
Sevelda
P
P
D002288:Adenocarcinoma, Mucinous / Q000097:blood / Q000401:mortality / Q000601:surgery; D000328:Adult; D000368:Aged; D000740:Anemia / Q000097:blood*; D002277:Carcinoma / Q000097:blood / Q000401:mortality / Q000601:surgery; D018269:Carcinoma, Endometrioid / Q000097:blood / Q000401:mortality / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006454:Hemoglobins / Q000032:analysis*; D006801:Humans; D008875:Middle Aged; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000097:blood* / Q000401:mortality / Q000601:surgery*; D011237:Predictive Value of Tests; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D013997:Time Factors
D006454:Hemoglobins